近日,Journal of Controlled Release杂志发表了题为Lipid nanoparticles produce chimeric antigen receptor T cells with interleukin-6 knockdown in vivo的论文,该论文的通讯作者为优卡迪创始人兼首席科学家俞磊博士。该研究用LNP递送实现体内制备CAR-T疗法,...
近日,Journal of Controlled Release杂志发表了题为Lipid nanoparticles produce chimeric antigen receptor T cells with interleukin-6 knockdown in vivo的论文,该论文的通讯作者为优卡迪创始人兼首席科学家俞磊博士。该研究用LNP递送实现体内制备CAR-T疗法,给目前CAR-T疗法的临床应用困境提供了潜在的解决方案。研究人员...